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A pneumococcal isolate that caused relapsing meningitis in a patient infected with hu-
man immunodeficiency virus (HIV) was found to display an unusual response to
penicillin - rapid death but a striking lack of cellular lysis. This lytic defect was also de-
tected in all four pneumococcal isolates from three additional HIV-infected patients and
in more than half of the clinical isolates from patients with bacteremia. In a rabbit model
of meningitis, the lysis-defective strain remained cryptic, with a delay of 5 h in the onset
of leukocytosis in cerebrospinal fluid. A marked burst of leukocytosis was associated with
ampicillin-induced lysis of a lysis-sensitive strain but not of a lysis-defective strain. Pneu-
mococcal clinical isolates have different lytic responses to penicillin; defective lysis may
adversely affect the course of meningitis, an observation suggesting that autolysins play
a role in modulating infectious diseases.
A nine-month-old child infected with human immu-
nodeficiency virus (HIV) developed relapsing pneu-
mococcal meningitis. After characterizing the strain,
we found an unusual response to penicillin- the bac-
terium died rapidly but did not undergo cellular ly-
sis. Classically, two responses to penicillin have been
described [1,2] for clinical isolates of pneumococci.
Typically, the isolates lyse and die rapidly; rarely, ly-
sis is nearly absent, and killing is substantially slower.
Wecharacterized in detail the dissociation of killing
and lysis in the strain from this patient. This report
also describes the discovery of clinical isolates of
pneumococci that do not lyse but that undergo rapid
loss of viability during penicillin treatment. Addi-
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tionally, our studies analyze the impact of the lack
of drug-induced lysis (independent of bacterial kill-
ing) on the clinical course of pneumococcal infec-
tions. We present evidence that autolysins may play
a role in modulating the course of some infectious
diseases.
Materials and Methods
Bacterial strains andgrowth conditions. We used
the following strains: encapsulated clinical strains
8249, Sm. Va2, Va3, and Va7 and unencapsulated
laboratory strain R6 and its tolerant transformant
Iyt 4-4; the strains have previously been described
[1-3]. Six clinical isolates from the pre-penicillin era
[4, 5] were obtained from the Centers for Disease
Control (Atlanta): SP-88, 96, 99, 108, 142, and 144
(MICs of penicillin, om IJ.g/mL). Thirty-three iso-
lates from blood or CSF were provided by the Arc-
tic Investigations Laboratory (Anchorage, Alaska)
as part of a retrospective study of invasive pneumo-
coccal disease in Southwest Alaska from 1980 to
1986. Serotypes included types 14 (13 strains), 19A
(9 strains), 04 (4 strains), 23F (2 strains), and 1strain
each of types lOA, 6B, 07F, 33F, and 18C; MICs of
penicillin ranged from 0.01 to 0.25 IJ.g/mL. One iso-
late was from an Alaskan infant with an immuno-
globulin deficiency and persistent meningitis. Five
isolates, including the index strain Br, wereobtained
from four HIV-infected patients with pneumococ-
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cal bacteremia or meningitis at New York Hospital
(New York; serotypes 19, 6, and 9; MICs of penicil-
lin, 0.02 ug/ml., including strain Br). Three of these
isolates caused relapsing disease in two patients:
strain Br caused meningitis that was controlled af-
ter two 14-dcourses of penicillin, and strains GI and
Gil caused recurrent bacteremia. Strain Br was tested
in the first passage and in ~1O passages from frozen
stock. MICs were determined by using the macro-
tube dilution method. Identification was made on
the basis of growth and morphology on blood-agar
plates and of sensitivity to optochin. All strains ex-
cept the autolysin-deficient strain Iyt 4-4 were lysed
by deoxycholate [2].
Strains were grown in semisynthetic medium sup-
plemented with 0.1070 yeast (Difco, Detroit) extract
(C +y; pH 8.0 [6]) in a stationary water bath at 37 C.
All experiments were carried out during exponen-
tial-growth phase from back-diluted overnight cul-
tures. Turbidity was monitored by using a Sequoia-
Turner spectrophotometer (absorbance at 620 nm;
Mountainville, Calif). Stocks of cultures were stored
in C +Y medium with 10% glycerol at - 70 C, by
using the first or second passage from the original
clinical isolate.
Lysis andkilling rates. Cultures of all strains were
divided in half when the turbidity reached an ab-
sorbance of 0.3-0.4; half of the cultures received 10
x MIC of penicillin. Strains R6 and Br were also
tested for lysis in the presence of ~100 x MIC of
penicillin and of 10 x MlC of imipenem (0.05
ug/rnl.), vancomycin (5 ug/ml.), or ampicillin (0.4
ug/rnl.). Turbidity was monitored for 6 h and over-
night. Viability was determined at 0, 2, and 4 h after
adding penicillin, by diluting samples from each cul-
ture in incomplete semisynthetic medium contain-
ing penicillinase (100 U/mL; Becton-Dickinson,
Cockeysville, Md) and by pour-plating in tryptic-soy
agar (Difco) supplemented with 3% sterile, defibri-
nated sheep blood. Colony counts were made after
24 h of incubation at 37 C.
To compare rates of cell wall degradation, wegrew
strains R6, lyt 4-4, and Br overnight in C +Ymedium
containing 1 ~Ci and 5 ug of [3H]choline/mL (1
~Ci/mM; Amersham, Boston). Cells were washed
by filtration and were grown for an additional 2 h
in nonradiolabeled medium. Half of each culture re-
ceived 10 x MIC of penicillin, and all cultures were
sampled at hourly intervals for 6 h to determine
[3H]cholinecounts remaining in the cellwall (the ma-
terial precipitated in boiling SDS [7]). In some ex-
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periments, 1 ug of purified pneumococcal autoly-
sin/mL (amidase [8]) was added 30 min before
penicillin. Crude cell sonicates of strain Br were pre-
pared and assessed for the presence of endogenous
autolytic activity in vitro, as previously described [1,
2]. The profile of the penicillin-binding proteins of
strain Br was compared with that of strain R6 by
using published procedures [3].
Meningitis model. Groups of four rabbits were
anaesthetized and placed in stereotaxic frames as pre-
viously described [9, 10]. Pneumococcal strains SIll
and Br were grown to logarithmic phase in C +Y
medium, washed, and resuspended in pyrogen-free
saline at a concentration of 103 cfu in 0.2 mL. After
removal of 0.3 mL of CSF, the preparations were in-
stilled into the cisterna magna. Cytochemical deter-
minations of CSF were repeated in each animal over
a 24-h period to document changes in the density
of leukocytes and the concentrations of glucose, pro-
tein, and lactic acid [10]. Bacterial titers in CSF were
determined on tryptic-soy agar containing 3% sheep
blood. To determine the effect of ampicillin treat-
ment on the course of the disease, we infected groups
of four rabbits with each strain but did not sample
these groups until 18h later, when infection was es-
tablished. After CSF sampling, half of the animals
in each group received 30 mg of ampicillin/kg iv as
a single bolus dose. Ampicillin levelsin CSF reached
a maximum ("'0.5 ug/ml.) 30 min after infusion
(>10 x MlC of both SIll and Br), a result that
agreed with previous results [9]. Cytochemical
parameters and bacterial titers in CSF were deter-
mined 4 and 24 h after administering ampicillin.
Summaries ofclinical data. The medical records
for the 30 Alaskan patients and their 156household
members were obtained and reviewed for antibiotic
usage for the six months preceding the index pneu-
mococcal infection. The duration of antibiotic us-
age (median number of days) was recorded and com-
pared by using a nonparametric statistical test. The
duration of fever and hospitalization (median num-
ber of days) for the 30 invasive pneumococcal ill-
nesses was similarly recorded and analyzed.
Results
Characteristics of lysis-defective pneumococci.
Unlike the standard lysis-sensitive/fast-kill (R6) and
lysis-defective/slow-kill (lyt 4-4) laboratory strains,
strain Br demonstrated an apparent dissociation of
lysis and killing (lysis sensitive/fast kill) in response
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Figure 1. Comparison of the killing
(a) and lysis(b) rates of representative
strains from each of the three groups
of pneumococci. Triangles, lysis-sen-
sitivestrain R6; circles, lysis-defective,
kill-sensitive strain Br; squares, kill-
resistant(tolerant)strain lyt 4-4;closed
symbols, penicillin concentration of 10
X MIC; and opensymbols, penicillin
concentration of 100 x MIC.
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to penicillin (figure 1). Penicillin lysis was minimal,
even at 100 x MIC (figure 1, open circles). When
rates of cell wall degradation between the penicillin-
sensitive, lysis-sensitive/fast-kill (R6) strain and strain
Br were compared, cell wall degradation of strain
Br was markedly reduced at both 10 x and 100 x
MIC (table 1); this response was also found with am-
picillin. Rapid lysis analogous to the R6 standard
strain was achieved, however, by two other inhibi-
tors of cell wall synthesis - imipenem and vancomy-
cin. The profile of penicillin-binding proteins for
strain Br (determined at saturating concentrations
of the radioactive penicillin) was the same as that
for the standard laboratory strain R6 (data not
shown).
Crude extracts of strain Br contained autolytic ac-
tivity capable of solubilizing >90070 of [3H]lysine la-
bel from the cell wall of strain R6 in vitro, a result
indicating the presence of active autolysin. This re-
sult was consistent with the fact that deoxycholate
also caused lysis and cell wall degradation of strain
Table 1. Percent lossof ['H]choline label from cellwall
4 h after treating strains R6 and Br with various lytic
stimuli.
Lytic stimulus
Penicillin 10 x MIC
(x MIC) of penicillin +
I ug of ami- 0.1010
Strain None 10 100 dase/mL* deoxycholate
R6 9 78 92 92 94
Br 7 17t 34t 87 96
* Purified autolysin of strain R6; results with amidase alone
were not different from results with no lytic stimulus.
t p < .01, as compared with strain R6by using the Student's
t test.
Br (table 1) and of all the other lysis-defective clini-
cal isolates of pneumococci that we studied (deoxy-
cholate-induced lysis is an autolysin-dependent
phenomenon [2]). The presence of deoxycholate-in-
duced lysis and extensive stationary-phase lysis, al-
beit delayed in onset, also indicated that the cell wall
of strain Br could be hydrolyzed by autologous en-
zyme. Adding exogenous purified autolysin to cul-
tures of strain Br, then adding 10 x MIC of penicil-
lin, resulted in lysis and cell wall degradation
comparable to that in the lysis-sensitive strain R6
(table 1).
Lysis-defective pneumococci in clinical isolates.
Figure 2 compares the lytic and killing responses af-
ter exposure to 10 x MIC of penicillin for the 51
clinical isolates that were studied. The three general
types of responses shown in figure 1 were observed:
group a, lysis sensitive and fast killed (16 strains,
31%); group b, lysis defective and fast killed (29
strains, 57%); and group c, lysis defective and slowly
killed (6 strains, 12%). The classic lysis-sensitive re-
sponse, defined as those isolates showing >50% de-
crease in turbidity after 4 h, was characteristic of the
standard laboratory strain R6 and 15clinical isolates
(including strain Sin, two pre-penicillin isolates, and
12 Alaskan strains). The remaining 35 strains were
lysis defective «50% decrease in turbidity after 4 h),
with a spectrum of slow-lysis rates. This group also
demonstrated a wide range of rates and degrees of
penicillin-induced killing. For the purposes of com-
parison, an arbitrary dividing line was established
to define fast vs. slow killing, as follows. The well-
characterized laboratory standard (strain R6) was ac-
tually the least kill-sensitive strain in group a (mean,
3.0 ± 0.6 log cfu/mL). This value minus one stan-
dard deviation (i.e., 2.4) was chosen as the cutoff
value for "lysis-sensitive and fast-killed" pneu-
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Figure 2. Scattergramcomparing percent lysis and log
killing of pneumococci 4 h after administration of 10 x
MIC of penicillin. Dashedlinesrepresent borderlinevalues
betweengroups, derivedas explainedin the text. A, lysis-
sensitive, kill-sensitive; B, lysis-defective, kill-sensitive; C,
lysis-defective, kill-resistant (tolerant); .., laboratory
strains, including R6 (R) and lyt 4-4 (L); ., clinical iso-
lates from Alaska; ., isolatesfrom HIV-infected patients
including Br (B); b.., previously well-characterized clini-
cal isolates, including SIll (S); and 0, isolates from the
pre-penicillin era.
mococci. On this basis, six strains were classified as
"lysis defective" and "slowly killed" (group c): the
tolerant laboratory standard strain lyt 4-4; the pre-
viously described [1] "tolerant" clinical isolates 8249,
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Va2, Va3, and Va7; and one Alaskan isolate. Group
b, the group with the largest number of strains (29
strains, 571Jfo of the total), was characterized by the
novel phenotype "lysis defective" but "fast killed"
in response to penicillin. The majority of these strains
were as highly kill sensitive (>4 log kill after 4 h) as
were the "normal," lysis-sensitive, fast-kill strains in
group a. Four of six isolates from the pre-penicillin
era, all five isolates from HIV-infected patients (in-
cluding strain Br), and 20 of the 33 Alaskan isolates
were in this lysis-defective group.
Table 2 describes the relation between lytic and
killing properties and the MIC and serotype of the
49 clinical isolates. Lysis-sensitive, kill-sensitive
strains were always penicillin susceptible (MIC <0.1
ug/ml.), and most strains were type 14. Tolerant
(lysis-defective, kill-resistant) strains were always in-
termediatelyor highly resistant to penicillin (MIC
>O.1llg/mL), and all but one (6B) were type 19. The
mean MIC of the lysis-defective group was some-
what elevated, but the strains were nearly evenly dis-
tributed above and below an MIC of 0.1 ug/rnl.,
The presence of stationary-phase lysis was highly
variable in these strains and was often markedly
delayed in onset. No relation between the lytic re-
sponse to penicillin and stationary-phase lysis was
found.
Experimental meningitis due to lysis-sensitive and
lysis-defective pneumococci. The lysis-sensitive
strain Sur has been studied extensively in the rabbit
model of meningitis [9, 10]. We compared the growth
rate, the onset of CSF abnormalities, and the re-
sponse to ampicillin of strain Sui with that of the
lysis-defective strain Br. Both strains were penicillin-
susceptible (MIC, 0.02 ug/ml.) isolates from chil-
dren with meningitis, and both strains had a dou-
bling time of "'60 min in vivo in CSF. For strain
Sin, the appearance of >100 leukocytes/ul, of CSF
occurred 9 h after infection at a density of 7 x 105
cfu/mL; in contrast, strain Br induced leukocytosis
only at 14 h after infection at a density of 7 x 107
cfu/mL. At 24 h after infection the bacterial den-
Table 2. Relation of lytic and killing properties to MIC and serotype of clinical strains.
MIC of penicillin (ug/rnl.) No. of strains
Group Mean ± SD Range Total Serotype 14 Serotype 19
Lysis sensitive/kill sensitive 0.026 ± 0.01 0.015-0.06 15 11 1
Lysis defective/kill sensitive 0.095 ± 0.08 0.02-0.25 29 2 8
Lysis defective/kill resistant 2.0 ± 2.3 0.2-6.0 5 0 4
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Table 3. Comparison of CSF cytochemistry and bacterial titers, 4 h after ampicillin therapy, of lysis-sensitive (SIll)
and lysis-defective (Br) pneumococci in a rabbit model of meningitis.
CSF cytochemistry"
No. (mean ± SD) of leukocytes at Change in
bacterial titer
Strain (no. Percent (mean ± SD
Treatment group of animals) 18 h 22 h change log cfu/mL)
Control SIll (6) 2647 ± 2606 5860 ± 4025 +221 + 1.5 ± 0.8
Br (8) 2775 ± 3616 1630 ± 1527 -59 +2.5 ± 1.2
Ampicillin Sill (7) 2651 ± 1678 19202 ± 8511 +724t -3.1 ± 0.9
Br (8) 3147 ± 2838 7370 ± 6929 +234 - 1.9 ± 1.1
" Treatment was initiated at 18 h of infection.
t p < .01 when compared with control.
sity of strain Br exceeded the density of Sm by 2
logs. At the same time, however, the leukocyte den-
sity and protein concentrations for strain Br re-
mained approximately one-third that of SIll.
Table 3 compares the course of meningitis due to
strains Sm and Br after treatment with ampicillin.
Without treatment, bacterial counts increased 2 logs
between 18 and 22 h for both strains, yet the leuko-
cyte density for strain Sm doubled and that for
strain Br decreased to approximately one-half. In
ampicillin-treated animals, both strains were killed,
and the change in bacterial titer was 2-3 logs (P
>0.1). The number of leukocytes appearing in the
CSF 4 h after the onset of lysis of strain Siu was,
however, a mean of six times greater than the values
before ampicillin, whereas the corresponding value
for the lysis-defective strain Br was only doubled (P
< .(01). Twenty-four hours after ampicillin, bacterial
titers in animals infected with strain Br all rebounded
to >3 logs, and all the animals died within 72 h.
Three-fourths of the animals infected with strain
SIll showed an increase in bacterial titers, but the
maximum value was only NIlog, and 50010 of these
animals survived (i.e., alive at seven days).
Previous antibioticexposure and clinical course
ofpatients withpneumococcal bacteremia. Table
4 compares the antibiotic exposure, before the in-
dex infection, of 30 Alaskan patients who had pneu-
mococcal bacteremia; 12patients had lysis-sensitive
strains, and 18had lysis-defective strains. No signifi-
cant difference could be detected between the me-
dian number of days of antibiotic usage by the two
groups for three to six months before hospitaliza-
tion, a result that eliminated any possible antibiotic-
related selection for the lysis defect. In fact, more
patients with lysis-defective than lysis-sensitive in-
fections did not receive any penicillin (8 of 18 vs. 1
of 12;P < .05). A review of the medical records for
Table 4. Previous antibiotic exposure and clinical course of 30 patients with pneumococcal bacteremia.
Pneumococcal response to penicillin
Therapy
Antibiotic exposure"
Days of penicillin therapy
Courses of penicillin therapy
Days of all 13-lactam therapy
Courses of all 13-lactam therapy
Days of all other antibiotic therapy
Clinical course of index infection
Days in hospital
Days of temperature >37.2 C
Lysis sensitive
(n = 12)
20.5 (0-70)
2.5 (0-7)
20.5 (0-70)
2.5 (0-7)
25.0 (0-133)
3.5 (0-6)
2.0 (0-4)
Lysis defective
(n = 18)
6.0 (0-42)
1.5 (0-5)
15.5 (0-22)
2.0 (0-8)
10.0 (0-160)
3.5 (0-14)
3.5 (0-7)
p
.06
.09
.19
.20
.78
NS
NS
NOTE. Data are median no. (range); NS = not significant, n = no. of patients.
• Antibiotic exposure during the six months before the index episode of pneumococcal bacteremia.
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all other members of households in which there was
a case of invasive pneumococcal infection showed
no difference in previous antibiotic usage.
The data on the clinical courses of the HIV-
infected patients and the Alaskan patients with bac-
teremia were available for retrospective study. Two
of the four HIV-infected patients and one immuno-
globulin-deficient child experienced relapsing or per-
sistent disease; all of the causative pneumococcal
strains were lysis defective. In particular, strain Br,
which caused relapsing meningitis in one of the HIV-
infected patients, was eradicated only after tandem,
14-day courses of penicillin and ampicillin. Menin-
gitis persisted in the immunoglobulin-deficient child
after 18 d of penicillin. In contrast, in normal, im-
munocompetent hosts, there were no differences de-
tected between the patients with lysis-sensitive and
lysis-defective strains after comparing days of hos-
pitalization or days with fever (>37.2 C), an obser-
vation suggesting that the lytic phenotype did not
influence the course of bacteremia (table 4).
Discussion
Our study shows that the response to penicillin in
clinical isolates of pneumococci varies considerably
with respect to bacterial lysis. Recently [1, 11], it has
become evident that decreased susceptibility to kill-
ing, i.e., tolerance, is increasing in frequency among
clinical isolates of pneumococci. Wenow report that
susceptibility to lysis is also changing in pneu-
mococci, and these properties may be independent
variables. Thus, it is possible to divide pneumococci
into three general response patterns to penicillin:
group a, both lysis and kill sensitive; group b, lysis
defective but kill sensitive; and group c, both rela-
tively lysis and kill resistant. The response to peni-
cillin of pneumococci in group a typifies the nor-
mal response that has been observed in the
laboratory strains extensively used over the past de-
cades, and the response of pneumococci in group
c characterizes a tolerant response. The existence of
group b pneumococci, in which lysis and killing are
dissociated, suggests that bacterial death and lysis
occur by different mechanisms in clinical isolates of
pneumococci. Killing without lysis and cell wall
degradation are properties that characterize most
strains of Lancefield group A streptococci [12, 13].
Penicillin-resistant pneumococci have previously
been shown [1] to be lysis defective, but they also
show a defect in killing, a result that is much more
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extensive than that described in figure 2 (compare
open triangles in group c and closed circles in group
b). Our data indicate that the combination of defec-
tive lysis and kill sensitivity is not rare among clini-
cal strains, because more than one-half of the strains
we tested demonstrated this trait. The actual preva-
lence of the lysis defect, with or without alteration
of sensitivity to killing, cannot be determined from
our data.
The lysis-defective pneumococci cannot be easily
recognized in the microbiology laboratory unless
they are characterized by using lysis-and-kill curves.
It is important to understand that a lytic defect can-
not be used as evidence for a kill defect in the clini-
cal microbiology laboratory. The lysis-defectivetrait
is clearly compatible with MICs characteristic of
highly sensitive (~O.02 ug/rnl.) bacteria. The selec-
tion pressure that is operative in generating lytic
defects in clinical isolates is not known. Recent lab-
oratory experiments [14] have demonstrated that
when penicillin is used in a cyclic (greater than the
MIC to less than the MIC) manner it selects for lysis-
defective pneumococci. This type of antibiotic pres-
sure characterizes antibiotic usage in the clinical set-
ting. Among the isolates collected from bacteremic
patients, however, the occurrence of antibiotic ther-
apy in both individuals and households before in-
fection was not more common in the patients with
lysis-defective than with lysis-sensitive strains. The
fact that isolates from the pre-penicillin era also dem-
onstrate this property suggests that other non-
antibiotic selective pressures, e.g., survival in stor-
age, also exist. It should be noted, however, that a
storage artifact does not adequately explain the lysis-
defective phenotype, because strain Br and six other
lysis-defective strains demonstrated the lysis-
defective phenotype after only one passage from the
clinical specimen. Additional studies [15] have shown
the trait to be genetically transformable.
The mechanism of the lytic defect in strain Br is
similar to that described for the tolerant South Afri-
can pneumococci [1] and in laboratory constructs
of lysis-defective strains [14]. The lytic defect mech-
anism may involve some aspect of autolysin control,
because strain Br lysed and degraded cell wall in re-
sponse to deoxycholate, imipenem, and vancomy-
cin, a result indicating that active autolysin and
hydrolysis-sensitive cell wall substrate were present.
Exogenous wild-type autolysin could depolymerize
the cell wall of penicillin-treated, lysis-defectivecells;
conversely, autolysin extracts of strain Br could de-
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grade wild-type cell wall in vitro. Thus, qualitatively,
the autolytic capacity of the lysis-defective strain Br
appeared to be intact but not triggered by penicillin.
Using a rabbit model of meningitis, weinvestigated
the autolytic defect to determine the clinical context
in which tests to detect the phenotype should be
done. A rigorous comparison of the course of in-
fection in lysis-defective vs. -sensitive strains would
require using isogenic strains of pneumococci, but
constructing such strains is difficult at the present
time, because no selection technique exists for com-
bining defective lysiswith kill sensitivity. Despite this
limitation, however, several obvious differences in
the course of infection were found. Clearly, infec-
tion progressed much further before leukocytes were
recruited into the CSF when rabbits were challenged
with the lysis-defectivestrain as opposed to the highly
lytic strain. Continued growth of the lysis-defective
strain did not result in increasing CSF leukocytosis.
The onset of leukocytosis in CSF has occurred be-
tween 0.7 and 1 x 106 cfu/mL for all pneumococci
tested thus far, regardless of capsular type [10]. Thus,
a delay of 5 h and an increase in the bacterial den-
sity to >107 cfu/mL before the onset of leukocytosis
for the lysis-defective strain is an important result.
The cryptic nature of infection with the lysis-
defective strain would contribute to higher morbidity
and mortality from this type of infection. It is known
that antibiotic-induced lysis and subsequent release
of cell wall-degradation products contribute to
generating inflammation in the CNS and the lung
[10, 16, 17]. By this criterion, the lysis-defective
strains would be expected to generate less inflam-
mation, particularly during antibiotic-induced cell
death in vivo.This result was indeed what was found;
and this result would be expected to improve the out-
come of disease once the cryptic infection was dis-
covered [16]. The rebound in bacterial titers 24 h af-
ter ampicillin was greater in the lysis-defectivestrains
than in the lysis-sensitive strains. Because both lysis-
defective and -sensitive strains were killed equally
well, this increase may be due to an insufficient num-
ber of leukocytes to control a cryptic infection of
high bacterial density.
Our results suggest that autolysis plays a role in
shaping the course of pneumococcal meningitis in
vivo, independent of the sensitivity of the bacterium
to antibiotic-induced death. Autolysins can be con-
sidered dual-edged swords because when they remain
cryptic (lysisdefective), recruitment of host defenses
to sites of infection outside the blood stream is slower
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and the rebound in bacterial growth after antibiot-
ics is greater. On the other hand, without lysis, in-
flammation associated with antibiotic-induced bac-
terial death is less prominent. There appears to be
a negative balance between these effects in ex-
perimental meningitis, a system that is highly sensi-
tive to the complications of lysis. Defective lysis,
however, may not require longer therapy when bac-
teremia occurs in normal children. A retrospective
comparison of the clinical course of 29 im-
munocompetent patients with invasive disease
caused by lysis-defective strains showed that this
property did not promote a relapsing or complicated
course for bacteremia. In four HIV-infected patients
and one immunoglobulin-deficient patient, however,
all six invasive infections were caused by lysis-
defective strains; three of the five patients experi-
enced relapsing or persistent disease. This result sug-
gests that a prospective analysis of the prevalence
and the impact on the clinical course of lysis-
defective pneumococci is warranted in immunocom-
promised patients and in severe invasivedisease such
as meningitis in the normal host.
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